ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,676Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 46

$522K Total Retail Price of All Prescriptions

Rank: 9 out of 46

419 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
24% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

8% of this provider’s 419 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

1% of this provider’s 9,600 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
SIMVASTATIN 371 335 1 6
OMEPRAZOLE 364 327 2 5
FUROSEMIDE 361 340 3 7
HYDROCHLOROTHIAZIDE 351 330 4 14
AMLODIPINE BESYLATE 351 326 4 8
ATORVASTATIN CALCIUM 283 248 6 20
METFORMIN HCL 279 260 7 9
WARFARIN SODIUM 227 210 8 13
LEVOTHYROXINE SODIUM 206 181 9 4
LOSARTAN POTASSIUM 186 176 10 31
ATENOLOL 173 163 11 18
HYDROCODONE-ACETAMINOPHEN 163 152 S3 12 1
PRAVASTATIN SODIUM 162 154 13 12
TAMSULOSIN HCL 162 149 13 25
METOPROLOL TARTRATE 157 145 15 10
PAROXETINE HCL 157 137 15 65
LISINOPRIL 136 123 17 3
POTASSIUM CHLORIDE 131 114 18 15
ZOLPIDEM TARTRATE 130 113 19 21
RAMIPRIL 127 115 20 134
BENAZEPRIL HCL 121 118 21 76
CARVEDILOL 107 106 22 29
ALLOPURINOL 96 92 23 40
ISOSORBIDE MONONITRATE ER 94 94 24 47
LOSARTAN-HYDROCHLOROTHIAZIDE 90 77 25 73
PLAVIX 89 85 26 75
METOPROLOL SUCCINATE 87 83 27 17
SERTRALINE HCL 86 54 28 22
GLIPIZIDE 86 86 28 70
CLOPIDOGREL 85 83 30 48
LIPITOR 83 79 31 105
SPIRONOLACTONE 83 83 31 67
ENALAPRIL MALEATE 82 79 33 85
AZITHROMYCIN 80 77 34 30
PANTOPRAZOLE SODIUM 79 67 35 52
GABAPENTIN 78 70 36 11
FLUOXETINE HCL 75 75 37 50
FLUTICASONE PROPIONATE 73 73 38 72
ADVAIR DISKUS 73 72 38 60
CITALOPRAM HBR 70 66 40 23
TRIAMTERENE-HCTZ 70 66 40 64
DIGOXIN 70 64 40 80
LANTUS 68 68 43 35
ENALAPRIL-HYDROCHLOROTHIAZIDE 67 67 44 187
SPIRIVA 63 41 45 68
LABETALOL HCL 63 57 45 193
AVODART 62 50 47 195
DONEPEZIL HCL 61 61 48 19
DIOVAN 59 59 49 77
KLOR-CON M20 59 55 49 58
QUINAPRIL HCL 59 53 49 201
VENLAFAXINE HCL 58 58 52 147
KLOR-CON M10 57 57 53 132
TERAZOSIN HCL 56 56 54 209
SINGULAIR 55 55 55 121
PREDNISONE 51 48 56 51
ALENDRONATE SODIUM 50 41 57 28
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 24, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.